{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:40:34Z","timestamp":1747179634519,"version":"3.40.5"},"reference-count":134,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"This paper was not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Gastroenterology &amp; Hepatology"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/17474124.2022.2093185","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T07:45:11Z","timestamp":1656315911000},"page":"601-624","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-7593","authenticated-orcid":false,"given":"Emily","family":"Harrold","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Mater Private Hospital Dublin, Leinster, Ireland"},{"name":"Trinity St James Cancer Institute, Trinity College Dublin, Leinster, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Corrigan","sequence":"additional","affiliation":[{"name":"Trinity St James Cancer Institute, Trinity College Dublin, Leinster, Ireland"},{"name":"Medical Oncology Department, Tallaght\/AMNCH Hospital Dublin, Leinster, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Barry","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, St James University Hospital Dublin, Leinster, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve","family":"Lowery","sequence":"additional","affiliation":[{"name":"Trinity St James Cancer Institute, Trinity College Dublin, Leinster, Ireland"},{"name":"Medical Oncology Department, St James University Hospital Dublin, Leinster, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0558"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.084145"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature20805"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61121-X"},{"key":"e_1_3_5_8_1","article-title":"Lapatinib in combination with capecitabine plus oxaliplatin in human epidermal growth factor receptor 2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma: TRIO-013\/LOGiC\u2013A Randomized Phase III Trial","volume":"34","author":"Hecht JR","unstructured":"Hecht JR, Bang YJ, Qin SK, et al. Lapatinib in combination with capecitabine plus oxaliplatin in human epidermal growth factor receptor 2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma: TRIO-013\/LOGiC\u2013A Randomized Phase III Trial. J Clin Oncol;34","journal-title":"J Clin Oncol"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30481-9"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30111-0"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.4013"},{"key":"e_1_3_5_12_1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2-J","article-title":"The prognostic significance of amplification and overexpression of c\u2010met and c\u2010erb B\u20102 in human gastric carcinomas","volume":"85","author":"Nakajima M","year":"1999","unstructured":"Nakajima M, Sawada H, Yamada Y, et al. The prognostic significance of amplification and overexpression of c\u2010met and c\u2010erb B\u20102 in human gastric carcinomas. Cancer: Interdiscip Int J Am Cancer Soc. 1999;85:1894\u20131902.","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(98)01359-2"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3205"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1261"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v7.i11.317"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0597-68"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1121"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.01.022"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604251"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.13687"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-1080"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/028418601750444204"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199812)23:4<307::AID-GCC5>3.0.CO;2-#"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.4928"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-015-0585-x"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.61"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301839"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.237"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181d3d29b"},{"key":"e_1_3_5_31_1","first-page":"S2","article-title":"E-cadherin gene alterations in gastric cancers in different ethnic populations","volume":"18","author":"Steinberg ML","year":"2008","unstructured":"Steinberg ML, Hwang B-J, and Tang L, et al. E-cadherin gene alterations in gastric cancers in different ethnic populations. Ethn Dis. 2008;18:S2\u2013S4.","journal-title":"Ethn Dis"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0070"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0737"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.7706"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6753"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26330"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.02.043"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203874"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.8.e26"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508776103"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<238::AID-CNCR31>3.0.CO;2-F"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.284166.116"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.84"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2791"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0040"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6031540"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.4296"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.718"},{"key":"e_1_3_5_49_1","first-page":"393","article-title":"Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells","volume":"3","author":"Kaji M","year":"1996","unstructured":"Kaji M, Yonemura Y, and Harada S, et al. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther. 1996;3:393.","journal-title":"Cancer Gene Ther"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<289::AID-IJC22>3.0.CO;2-5"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.11.4731"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70623-4"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0839"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(92)90350-H"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.09.003"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.01135.x"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0477"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2012.670865"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.01.015"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2014-728"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0365"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4443"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0934"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-015-0545-5"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1828"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15457"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0748"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0175"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2011-4717"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.3_suppl.2"},{"issue":"15","key":"e_1_3_5_71_1","article-title":"MetGastric: a randomized phase III study of onartuzumab (MetMAb) in combination with mFOLFOX6 in patients with metastatic HER2-negative and MET-positive adenocarcinoma of the stomach or gastroesophageal junction","volume":"31","author":"Cunningham D","year":"2013","unstructured":"Cunningham D, Bang YJ, and Taberno J, et al. MetGastric: a randomized phase III study of onartuzumab (MetMAb) in combination with mFOLFOX6 in patients with metastatic HER2-negative and MET-positive adenocarcinoma of the stomach or gastroesophageal junction. J Clin Oncol 2013 . 31(15):suppl","journal-title":"J Clin Oncol"},{"issue":"15","key":"e_1_3_5_72_1","article-title":"METGastric: a phase III study of onartuzumab plus mFOLFOX6 in patients with metastatic HER2-negative (HER2-) and MET-positive (MET+) adenocarcinoma of the stomach or gastroesophageal junction (GEC)","volume":"33","author":"Shah MA","year":"2015","unstructured":"Shah MA, Bang YJ, and Lordick F, et al. METGastric: a phase III study of onartuzumab plus mFOLFOX6 in patients with metastatic HER2-negative (HER2-) and MET-positive (MET+) adenocarcinoma of the stomach or gastroesophageal junction (GEC). J Clin Oncol. 2015;33(15):suppl.","journal-title":"J Clin Oncol"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30566-1"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.3_suppl.tps226"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0543"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1819085116"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1418"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-016-0370-7"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054014"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-013-0057-2"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.08.015"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0442"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1341"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1337"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1749"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.9004"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004407"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa042"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14254"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4721"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.03.120"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0436"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11156"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11219"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1623"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-014-1001-3"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-014-0360-4"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1159\/000011898"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2771"},{"key":"e_1_3_5_100_1","first-page":"553","article-title":"C-met is amplified but not mutated in a cell line with an activated met tyrosine kinase","volume":"6","author":"Ponzetto C","year":"1991","unstructured":"Ponzetto C, Giordano S, Peverali F, et al. C-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene. 1991;6:553\u2013559.","journal-title":"Oncogene"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401427c"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.06.013"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0686"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.09.119"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm2007613"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0140"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00386"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.126"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0395"},{"issue":"3","key":"e_1_3_5_110_1","article-title":"Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified gastroesophageal junction (GEJ), gastric (G), or esophageal (E) cancer","volume":"33","author":"Kwak EL","year":"2015","unstructured":"Kwak EL, LoRusso P, and Hamid O, et al. Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified gastroesophageal junction (GEJ), gastric (G), or esophageal (E) cancer. Journal of Clinical Oncology. 2015;33(3):suppl 1.","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00174.2006"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1994.13.1189"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1359"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11426"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03096"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00085-0"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2135113100"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0561-9"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32557-1"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.18_suppl.lba4509"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.12.78"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.49"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4406"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14407"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.14"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25472"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.252"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.09.012"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.1481"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0189"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1363137"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004413"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0071"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00662"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-5239"}],"container-title":["Expert Review of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474124.2022.2093185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T14:49:41Z","timestamp":1708958981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474124.2022.2093185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":134,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/17474124.2022.2093185"],"URL":"https:\/\/doi.org\/10.1080\/17474124.2022.2093185","relation":{},"ISSN":["1747-4124","1747-4132"],"issn-type":[{"type":"print","value":"1747-4124"},{"type":"electronic","value":"1747-4132"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierh20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierh20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}